| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |